glp-1 dose conversion chart Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are glp-1 dose conversion glp 1

Psychiatry 23 , 443444 (2008)

10.1529/biophysj.104.056085 28 MosharovE.CranfordM

Researchers use GHK-Cu as a copper-binding peptide model for studying peptide signaling, gene expression, and extracellular-matrix-related pathways

At the 2.5 mg tirzepatide starting dose (0.25 mL), the injection delivers 25 mg of levocarnitine

The process of pyroptosis mainly involves the caspase-1-dependent pathway (classical pathway) and the caspase-1-independent pathway (non-classical pathway), and is closely related to the secretion and activation of the pro-inflammatory cytokines interleukin-1 (IL-1) and IL-18, which play an important role in inflammatory response and immune defense through the release of inflammatory mediators and the recruitment of immune cells (103105)